Engaging new partners to save lives
	The Global Health Innovative Technology Fund (GHIT Fund), along with the New York Academy of Sciences and Japan Society, will host a panel discussion - comprised of preeminent global health experts - to examine recent successes and setbacks in global health and what they see as the secret ingredient to moving a vaccine, cure or diagnostic across the finish line and into the field.
	Panelists will provide their unique perspectives on: 
	- 
		How do these partnerships find success in the face of seemingly insurmountable challenges?
 
	- 
		What have we learned from past successes that make the difference between a breakthrough diagnostic or treatment and a trip back to the drawing board?
 
	- 
		Where are the opportunities for the next big solutions?
 
	- 
		Who is missing from the table in the effort to push back against HIV, TB, malaria and neglected tropical diseases?
 
	- 
		Why should those outside the global health and NGO worlds join this effort?
 
	The discussion will include an opportunity for questions from attendees. A networking reception will follow the panel.
	When:6-8:30pm
	November 12, 2013
	Who:
	Panelists:
	- 
		Peter Piot, M.D., Ph.D.
		Director, London School of Hygiene & Tropical Medicine; Former Executive Director of UNAIDS; GHIT Fund Board Member 
	- 
		Ann M. Veneman, J.D.
		Former Executive Director of UNICEF; Former Secretary of Agriculture; GHIT Fund Board Member 
	- 
		Mel Spigelman, M.D. 
		President and CEO, Global Alliance for TB Drug Development (TB Alliance); GHIT Fund Grantee 
	- 
		Kiyoshi Kurokawa, M.D. 
		Chair of the Board of GHIT Fund; Academic Fellow, National Graduate Institute for Policy Studies; Chairman, Health and Global Policy Institute 
	Moderated:
	- 
		Ko-Yung Tung, J.D.
		Senior Counselor, Morrison & Foerster; GHIT Fund Board Advisor 
	Where:
	Japan Society
	333 East 47th Street
	New York, NY 10017